Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2009 - 2026)

Zimmer Biomet Holdings' Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$369.2 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 164.16% year-over-year to -$369.2 million in Q1 2026; TTM through Mar 2026 was -$618.6 million, a 538.72% decrease from a year earlier, with the FY2025 full-year figure at $326.0 million, up 167.29% from the prior year.
• Cash from Financing Activities improved to -$369.2 million in Q1 2026 per ZBH's latest filing, from -$897.0 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $575.4 million in Q1 2025 and bottomed at -$897.0 million in Q4 2025.
• The 5-year median for Cash from Financing Activities is -$146.0 million (2022), against an average of -$121.6 million.
• Across the five-year window, Cash from Financing Activities tumbled 415.9% in 2022 and surged 1248.5% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$313.4 million in 2022, then advanced by 19.78% to -$251.4 million in 2023, then advanced by 4.3% to -$240.6 million in 2024, then slumped by 272.82% to -$897.0 million in 2025, then soared by 58.84% to -$369.2 million in 2026.
• Per Business Quant, the three latest ZBH Cash from Financing Activities figures stand at -$369.2 million (Q1 2026), -$897.0 million (Q4 2025), and $483.8 million (Q3 2025).